---
document_datetime: 2025-11-23 07:03:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/viraferon.html
document_name: viraferon.html
version: success
processing_time: 0.1015154
conversion_datetime: 2025-12-24 19:06:04.17865
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Viraferon

[RSS](/en/individual-human-medicine.xml/65767)

##### Withdrawn

This medicine's authorisation has been withdrawn

interferon alfa-2b

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 9 March 2000, the European Commission granted a marketing authorisation valid throughout the European Union (EU) for the medicinal product Viraferon (interferon alfa-2b), indicated for the treatment of chronic hepatitis B and chronic hepatitis C.

On 19 September 2008, the marketing authorisation holder (MAH) responsible for Viraferon, Schering-Plough Europe, notified the European Commission of its decision to voluntarily withdraw the marketing authorisation for Viraferon for commercial reasons. The MAH confirmed that this decision is not related to any safety concerns with Viraferon. Viraferon had not been marketed anywhere in the European Union (EU) since early 2007. IntronA is an identical product containing interferon alfa-2b that is available in all areas of the EU, and in particular where Viraferon was previously available.

On 13 October 2008, the European Commission issued a decision to withdraw the marketing authorisation for Viraferon. Pursuant to this decision, the European public assessment report (EPAR) for Viraferon is updated to reflect that the marketing authorisation is no longer valid.

Viraferon : EPAR - Summary for the public

English (EN) (263.3 KB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/overview/viraferon-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-253)

български (BG) (430.11 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/bg/documents/overview/viraferon-epar-summary-public_bg.pdf)

español (ES) (266.22 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/es/documents/overview/viraferon-epar-summary-public_es.pdf)

čeština (CS) (407.42 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/cs/documents/overview/viraferon-epar-summary-public_cs.pdf)

dansk (DA) (265 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/da/documents/overview/viraferon-epar-summary-public_da.pdf)

Deutsch (DE) (266.63 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/de/documents/overview/viraferon-epar-summary-public_de.pdf)

eesti keel (ET) (260.96 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/et/documents/overview/viraferon-epar-summary-public_et.pdf)

ελληνικά (EL) (426.81 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/el/documents/overview/viraferon-epar-summary-public_el.pdf)

français (FR) (265.46 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/fr/documents/overview/viraferon-epar-summary-public_fr.pdf)

italiano (IT) (264.93 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/it/documents/overview/viraferon-epar-summary-public_it.pdf)

latviešu valoda (LV) (413.88 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/lv/documents/overview/viraferon-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (624.35 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/lt/documents/overview/viraferon-epar-summary-public_lt.pdf)

magyar (HU) (398.15 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/hu/documents/overview/viraferon-epar-summary-public_hu.pdf)

Malti (MT) (412.56 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/mt/documents/overview/viraferon-epar-summary-public_mt.pdf)

Nederlands (NL) (266.19 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/nl/documents/overview/viraferon-epar-summary-public_nl.pdf)

polski (PL) (415.23 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/pl/documents/overview/viraferon-epar-summary-public_pl.pdf)

português (PT) (265.26 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/pt/documents/overview/viraferon-epar-summary-public_pt.pdf)

română (RO) (375.24 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/ro/documents/overview/viraferon-epar-summary-public_ro.pdf)

slovenčina (SK) (402.27 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sk/documents/overview/viraferon-epar-summary-public_sk.pdf)

slovenščina (SL) (393.33 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sl/documents/overview/viraferon-epar-summary-public_sl.pdf)

Suomi (FI) (261.9 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/fi/documents/overview/viraferon-epar-summary-public_fi.pdf)

svenska (SV) (263.9 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sv/documents/overview/viraferon-epar-summary-public_sv.pdf)

## Product information

Viraferon : EPAR - Product Information

English (EN) (3.66 MB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/product-information/viraferon-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-673)

български (BG) (7.04 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/bg/documents/product-information/viraferon-epar-product-information_bg.pdf)

español (ES) (4.2 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/es/documents/product-information/viraferon-epar-product-information_es.pdf)

čeština (CS) (5.43 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/cs/documents/product-information/viraferon-epar-product-information_cs.pdf)

dansk (DA) (3.98 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/da/documents/product-information/viraferon-epar-product-information_da.pdf)

Deutsch (DE) (4.5 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/de/documents/product-information/viraferon-epar-product-information_de.pdf)

eesti keel (ET) (4.01 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/et/documents/product-information/viraferon-epar-product-information_et.pdf)

ελληνικά (EL) (7.64 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/el/documents/product-information/viraferon-epar-product-information_el.pdf)

français (FR) (4.3 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/fr/documents/product-information/viraferon-epar-product-information_fr.pdf)

italiano (IT) (2.87 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/it/documents/product-information/viraferon-epar-product-information_it.pdf)

latviešu valoda (LV) (6.05 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/lv/documents/product-information/viraferon-epar-product-information_lv.pdf)

lietuvių kalba (LT) (4.8 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/lt/documents/product-information/viraferon-epar-product-information_lt.pdf)

magyar (HU) (4.96 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/hu/documents/product-information/viraferon-epar-product-information_hu.pdf)

Malti (MT) (5.1 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/mt/documents/product-information/viraferon-epar-product-information_mt.pdf)

Nederlands (NL) (4.28 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/nl/documents/product-information/viraferon-epar-product-information_nl.pdf)

polski (PL) (5.84 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/pl/documents/product-information/viraferon-epar-product-information_pl.pdf)

português (PT) (4.25 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/pt/documents/product-information/viraferon-epar-product-information_pt.pdf)

română (RO) (5.22 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/ro/documents/product-information/viraferon-epar-product-information_ro.pdf)

slovenčina (SK) (4.98 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sk/documents/product-information/viraferon-epar-product-information_sk.pdf)

slovenščina (SL) (3.65 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sl/documents/product-information/viraferon-epar-product-information_sl.pdf)

Suomi (FI) (3.91 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/fi/documents/product-information/viraferon-epar-product-information_fi.pdf)

svenska (SV) (5.09 MB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sv/documents/product-information/viraferon-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0059 22/04/2008

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Viraferon : EPAR - All Authorised presentations

English (EN) (292.71 KB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_en.pdf)

[Other languages (20)](#file-language-dropdown-483)

български (BG) (355.76 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/bg/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_bg.pdf)

español (ES) (293.57 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/es/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_es.pdf)

čeština (CS) (347.55 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/cs/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (298.13 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/da/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (301.99 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/de/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (295.84 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/et/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (350.77 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/el/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_el.pdf)

français (FR) (293.88 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/fr/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (293.17 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/it/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (342.64 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/lv/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (344.23 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/lt/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (342.06 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/hu/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (294.31 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/nl/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_nl.pdf)

polski (PL) (347.46 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/pl/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_pl.pdf)

português (PT) (313.08 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/pt/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_pt.pdf)

română (RO) (322.37 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/ro/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (341.99 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sk/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (328.23 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sl/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (288.01 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/fi/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (298.37 KB - PDF)

**First published:**

27/05/2008

**Last updated:**

27/05/2008

[View](/sv/documents/all-authorised-presentations/viraferon-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Viraferon Active substance interferon alfa-2b International non-proprietary name (INN) or common name interferon alfa-2b Therapeutic area (MeSH)

- Hepatitis C, Chronic
- Hepatitis B, Chronic

Anatomical therapeutic chemical (ATC) code L03AB05

### Pharmacotherapeutic group

Immunostimulants

### Therapeutic indication

**Chronic Hepatitis B:**

**Chronic Hepatitis C:** *Adult patients:* IntronA is indicated for the treatment of adult patients with chronic hepatitis C who have elevated transaminases without liver decompensation and who are positive for serum HCV-RNA or anti-HCV (see section 4.4).

The best way to use IntronA in this indication is in combination with ribavirin.

*Chidren and adolescents:* IntronA is intended for use, in a combination regimen with ribavirin, for the treatment of children and adolescents 3 years of age and older, who have chronic hepatitis C, not previously treated, without liver decompensation, and who are positive for serum HCV-RNA. The decision to treat should be made on a case by case basis, taking into account any evidence of disease progression such as hepatic inflammation and fibrosis, as well as prognostic factors for response, HCV genotype and viral load. The expected benefit of treatment should be weighed against the safety findings observed for paediatric subjects in the clinical trials (see sections 4.4, 4.8 and 5.1).

## Authorisation details

EMA product number EMEA/H/C/000282 Marketing authorisation holder

Schering-Plough Europe

SP Europe Rue de Stalle, 73 B-1180 Bruxelles Belgium

Marketing authorisation issued 09/03/2000 Withdrawal of marketing authorisation 13/10/2008 Revision 11

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Viraferon : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (314.88 KB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/procedural-steps-after/viraferon-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Viraferon : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (322.63 KB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/steps-after-cutoff/viraferon-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Viraferon : EPAR - Scientific Discussion

English (EN) (526.73 KB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/scientific-discussion/viraferon-epar-scientific-discussion_en.pdf)

Viraferon : EPAR - Procedural steps taken before authorisation

English (EN) (312.03 KB - PDF)

**First published:** 27/05/2008

**Last updated:** 27/05/2008

[View](/en/documents/procedural-steps/viraferon-epar-procedural-steps-taken-authorisation_en.pdf)

**This page was last updated on** 19/11/2008

## Share this page

[Back to top](#main-content)